Tofacitinib for refractory ocular mucous membrane pemphigoid

PURPOSE: To report the successful use of tofacitinib in the treatment of refractory ocular mucous membrane pemphigoid (MMP). OBSERVATIONS: Two patients with ocular MMP presented with refractory disease after failure of multiple therapies. Treatment with tofacitinib led to durable control of conjunct...

Descripción completa

Detalles Bibliográficos
Autores principales: James, Hayley, Paley, Grace L., Brasington, Richard, Custer, Philip L., Margolis, Todd P., Paley, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111584/
https://www.ncbi.nlm.nih.gov/pubmed/34007952
http://dx.doi.org/10.1016/j.ajoc.2021.101104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111584/
https://www.ncbi.nlm.nih.gov/pubmed/34007952
http://dx.doi.org/10.1016/j.ajoc.2021.101104

Ejemplares similares